Cargando…

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)

Recurrence in patients with glioblastoma (GBM) is inevitable resulting in short survival times, even in patients with O-6-Methylguanine-DNA Methyltransferase (MGMT) methylation. Other pathways must be activated to escape from temozolomide (TMZ) treatment, however acquired resistance mechanisms to TM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Wendy, Sevim-Nalkiran, Hatice, Zaman, Ashraf M., Matsuda, Kazuko, Khasraw, Mustafa, Nowak, Anna K., Chung, Liping, Baxter, Robert C., McDonald, Kerrie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393433/ https://www.ncbi.nlm.nih.gov/pubmed/30814573 http://dx.doi.org/10.1038/s41598-019-39427-4

Ejemplares similares

MIF: functions in brain and glioblastoma
por: Ohta, Shigeki, et al.
Publicado: (2017)

Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
por: Babu, Suma, et al.
Publicado: (2021)

Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer
por: Sevim Nalkiran, Hatice, et al.
Publicado: (2023)

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
por: Sim, Hao-Wen, et al.
Publicado: (2021)

Role of phosphodiesterase inhibitor Ibudilast in morphine-induced hippocampal injury
por: Zhaleh, Mohsen, et al.
Publicado: (2014)

Combination of palbociclib and radiotherapy for glioblastoma
por: Whittaker, Shane, et al.
Publicado: (2017)

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
por: Sim, Hao-Wen, et al.
Publicado: (2023)

Brain Miffed by Macrophage Migration Inhibitory Factor
por: Savaskan, Nic E., et al.
Publicado: (2012)

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
por: Schwenkgrub, Joanna, et al.
Publicado: (2017)

Signal Transduction of Improving Effects of Ibudilast on Methamphetamine Induced Cell Death
por: Tahvilian, Reza, et al.
Publicado: (2019)

Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype
por: Goodman, Andrew D., et al.
Publicado: (2021)

Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies
por: Lu, Victor M., et al.
Publicado: (2020)

Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
por: Soumoy, Laura, et al.
Publicado: (2019)

Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema
por: Vasella, Mauro, et al.
Publicado: (2023)

Expression and Function of Macrophage Migration Inhibitory Factor (MIF) in Melioidosis
por: Wiersinga, W. Joost, et al.
Publicado: (2010)

Ibudilast Mitigates Delayed Bone Healing Caused by Lipopolysaccharide by Altering Osteoblast and Osteoclast Activity
por: Chang, Yuhan, et al.
Publicado: (2021)

MECHANISM OF ACTION OF MIGRATION INHIBITORY FACTOR (MIF) : I. EVIDENCE FOR A RECEPTOR FOR MIF PRESENT ON THE PERITONEAL MACROPHAGE BUT NOT ON THE ALVEOLAR MACROPHAGE
por: Leu, Richard W., et al.
Publicado: (1972)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial
por: Burnette, Elizabeth M., et al.
Publicado: (2020)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis
por: Bezdek, Siegfried, et al.
Publicado: (2018)

The Role of Macrophage Migration Inhibitory Factor (MIF) in Asthmatic Airway Remodeling
por: Li, Ruyi, et al.
Publicado: (2020)

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma
por: Alban, Tyler J., et al.
Publicado: (2023)

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
por: Jue, Toni Rose, et al.
Publicado: (2017)

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
por: Kagitani-Shimono, Kuriko, et al.
Publicado: (2005)

Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta
por: Faria, Miriam R, et al.
Publicado: (2010)

Inflammation and cancer: macrophage migration inhibitory factor (MIF)—the potential missing link
por: Conroy, H., et al.
Publicado: (2010)

Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
por: Verjans, Eva, et al.
Publicado: (2009)

Macrophage Migration Inhibitory Factor (MIF): A Key Player in Protozoan Infections
por: de Dios Rosado, Juan, et al.
Publicado: (2011)

The Role of Macrophage Migration Inhibitory Factor (MIF) in Ultraviolet Radiation-Induced Carcinogenesis
por: Shimizu, Tadamichi
Publicado: (2010)

Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension
por: Ahmed, Mohamed, et al.
Publicado: (2018)

1677 Macrophage migration inhibitory factor (MIF) promotes clearance of pneumococcal colonization
por: Das, Rituparna, et al.
Publicado: (2014)

Macrophage Migration Inhibitory Factor (MIF) as a Stress Molecule in Renal Inflammation
por: Kong, Yao-Zhong, et al.
Publicado: (2022)

Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme
por: Lee, Shin Heon, et al.
Publicado: (2021)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown
por: Schrader, Jörg, et al.
Publicado: (2009)

Serum Levels of Migration Inhibitory Factor (MIF) and In Situ Expression of MIF and Its Receptor CD74 in Lepromatous Leprosy Patients: A Preliminary Report
por: Martinez-Guzman, Marco Alonso, et al.
Publicado: (2018)

Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas
por: Wei, Q.T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jf55kfmvo3i77qqi5gkr695nda